We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+14.32%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
-$724M
(-23%)
Cap. Flow
-$938M
Cap. Flow
% of AUM
-37.88%
Top 10 Holdings %
Top 10 Hldgs %
48.15%
Holding
67
New
27
Increased
10
Reduced
11
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$95.9M |
| 2 |
AGN
Allergan plc
AGN
|
+$89.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$62.5M |
| 4 |
Centene
CNC
|
+$61.7M |
| 5 |
UnitedHealth
UNH
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$165M |
| 2 |
CVS Health
CVS
|
+$144M |
| 3 |
LivaNova
LIVN
|
+$139M |
| 4 |
Intuitive Surgical
ISRG
|
+$135M |
| 5 |
CELG
Celgene Corp
CELG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38M | 1.53% |
+730,760
| New | +$33.7M |
|
|
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
| $37.3M | 1.51% |
+1,186,830
| New | +$36M |
|
|
CVRS
28
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $34.8M | 1.4% |
19,981,655
| – | – |
|
|
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
| $34.7M | 1.4% |
+1,398,300
| New | +$35.1M |
|
|
VRAY
30
DELISTED
ViewRay, Inc.
VRAY
| $31M | 1.25% |
4,192,550
-311,080
| -7% | -$2.4M |
|
31
CONMED
CNMD
$1.39B
| $28.2M | 1.14% |
+339,500
| New | +$24.7M |
|
|
MDCO
32
CALL
DELISTED
Medicines Co
MDCO
| $27.9M | 1.13% |
+1,000,000
| New | +$23.6M |
|
33
Pacira BioSciences
PCRX
$1.04B
| $26.9M | 1.09% |
706,379
-1,791,749
| -72% | -$69.9M |
|
|
34
CALL
CVS Health
CVS
$133B
| $21.6M | 0.87% |
+400,000
| New | +$24.7M |
|
|
MDCO
35
DELISTED
Medicines Co
MDCO
| $20.8M | 0.84% |
745,910
-2,125,373
| -74% | -$50.1M |
|
36
HCA Healthcare
HCA
$87.2B
| $19.1M | 0.77% |
+146,810
| New | +$19.7M |
|
|
NVRO
37
DELISTED
NEVRO CORP.
NVRO
| $16.1M | 0.65% |
256,990
+101,580
| +65% | +$4.78M |
|
38
iRhythm Holdings
IRTC
$3.85B
| $15.9M | 0.64% |
+211,630
| New | +$18.1M |
|
39
Iovance Biotherapeutics
IOVA
$1.82B
| $11.4M | 0.46% |
+1,198,190
| New | +$11.6M |
|
40
PUT
Ionis Pharmaceuticals
IONS
$8.6B
| $10.1M | 0.41% |
+125,000
| New | +$8.06M |
|
41
Ironwood Pharmaceuticals
IRWD
$696M
| $10.1M | 0.41% |
+892,154
| New | +$9.96M |
|
42
Abbott
ABT
$183B
| $9.55M | 0.39% |
+119,470
| New | +$8.89M |
|
|
SEM
43
DELISTED
Select Medical
SEM
| $8.45M | 0.34% |
+1,113,600
| New | +$8.95M |
|
|
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.83M | 0.32% |
+152,040
| New | +$6.57M |
|
|
GNFT
45
DELISTED
Genfit
GNFT
| $7.8M | 0.32% |
+325,000
| New | +$7.5M |
|
|
PTE
46
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $4.28M | 0.17% |
16,000
-12,852
| -45% | -$4.76M |
|
|
CBAY
47
DELISTED
Cymabay Therapeutics
CBAY
| $2.98M | 0.12% |
+224,640
| New | +$2.39M |
|
48
Precision BioSciences
DTIL
$180M
| $2.69M | 0.11% |
+5,000
| New | +$2.65M |
|
49
Karyopharm Therapeutics
KPTI
$43.5M
| $1.73M | 0.07% |
+19,742
| New | +$2.19M |
|
|
AMRN
50
Amarin Corp
AMRN
$299M
| – | – |
-152,304
| Closed | -$41.5M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q1 2019 Portfolio in Review
As of Q1 2019, HealthCor Management held 67 positions worth $2.48B, down 23% from $3.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
HealthCor Management withdrew a net $938M in Q1 2019, closing 18 positions and reducing 11 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $165M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 75% a quarter earlier.
Against the trend, HealthCor Management opened a new position in Allergan plc worth $90.4M.
- HealthCor Management's largest Q1 2019 buy was Allergan plc: 617,760 shares worth $90.4M.
- HealthCor Management added most to Zimmer Biomet in Q1 2019, an estimated $95.9M increase.
- HealthCor Management's biggest Q1 2019 reduction was Intuitive Surgical, cutting an estimated $135M.
- HealthCor Management fully exited Regeneron Pharmaceuticals in Q1 2019, selling an estimated $165M.
- HealthCor Management's ten largest holdings make up 48% of its $2.48B portfolio in Q1 2019.
- HealthCor Management opened 27 new positions and closed 18 in Q1 2019.
- HealthCor Management's portfolio value fell 23% quarter-over-quarter to $2.48B.
Based on HealthCor Management's 13F filing for Q1 2019, filed 15 May 2019.